Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

11,562 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Detachment from the primary site and suspension in ascites as the initial step in metabolic reprogramming and metastasis to the omentum in ovarian cancer.
Sato M, Kawana K, Adachi K, Fujimoto A, Yoshida M, Nakamura H, Nishida H, Inoue T, Taguchi A, Ogishima J, Eguchi S, Yamashita A, Tomio K, Komatsu A, Wada-Hiraike O, Oda K, Nagamatsu T, Osuga Y, Fujii T. Sato M, et al. Among authors: inoue t. Oncol Lett. 2018 Jan;15(1):1357-1361. doi: 10.3892/ol.2017.7388. Epub 2017 Nov 9. Oncol Lett. 2018. PMID: 29399186 Free PMC article.
Low uptake of fluorodeoxyglucose in positron emission tomography/computed tomography in ovarian clear cell carcinoma may reflect glutaminolysis of its cancer stem cell-like properties.
Sato M, Kawana K, Adachi K, Fujimoto A, Taguchi A, Fujikawa T, Yoshida M, Nakamura H, Nishida H, Inoue T, Ogishima J, Eguchi S, Yamashita A, Tomio K, Arimoto T, Wada-Hiraike O, Oda K, Nagamatsu T, Osuga Y, Fujii T. Sato M, et al. Among authors: inoue t. Oncol Rep. 2017 Mar;37(3):1883-1888. doi: 10.3892/or.2017.5398. Epub 2017 Jan 20. Oncol Rep. 2017. PMID: 28112360
Targeting glutamine metabolism and the focal adhesion kinase additively inhibits the mammalian target of the rapamycin pathway in spheroid cancer stem-like properties of ovarian clear cell carcinoma in vitro.
Sato M, Kawana K, Adachi K, Fujimoto A, Yoshida M, Nakamura H, Nishida H, Inoue T, Taguchi A, Ogishima J, Eguchi S, Yamashita A, Tomio K, Wada-Hiraike O, Oda K, Nagamatsu T, Osuga Y, Fujii T. Sato M, et al. Among authors: inoue t. Int J Oncol. 2017 Apr;50(4):1431-1438. doi: 10.3892/ijo.2017.3891. Epub 2017 Feb 23. Int J Oncol. 2017. PMID: 28259988
Intraperitoneal neutrophils activated by KRAS-induced ovarian cancer exert antitumor effects by modulating adaptive immunity.
Yoshida M, Taguchi A, Kawana K, Ogishima J, Adachi K, Kawata A, Nakamura H, Sato M, Fujimoto A, Inoue T, Tomio K, Mori M, Nagamatsu T, Arimoto T, Koga K, Hiraike OW, Oda K, Kiyono T, Osuga Y, Fujii T. Yoshida M, et al. Among authors: inoue t. Int J Oncol. 2018 Oct;53(4):1580-1590. doi: 10.3892/ijo.2018.4504. Epub 2018 Jul 26. Int J Oncol. 2018. PMID: 30066851 Free PMC article.
Decreased expression of the plasminogen activator inhibitor type 1 is involved in degradation of extracellular matrix surrounding cervical cancer stem cells.
Sato M, Kawana K, Adachi K, Fujimoto A, Yoshida M, Nakamura H, Nishida H, Inoue T, Taguchi A, Takahashi J, Kojima S, Yamashita A, Tomio K, Nagamatsu T, Wada-Hiraike O, Oda K, Osuga Y, Fujii T. Sato M, et al. Among authors: inoue t. Int J Oncol. 2016 Feb;48(2):829-35. doi: 10.3892/ijo.2015.3283. Epub 2015 Dec 9. Int J Oncol. 2016. PMID: 26676222
STAT3 activity regulates sensitivity to tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in cervical cancer cells.
Nakamura H, Taguchi A, Kawana K, Kawata A, Yoshida M, Fujimoto A, Ogishima J, Sato M, Inoue T, Nishida H, Furuya H, Tomio K, Eguchi S, Mori-Uchino M, Yamashita A, Adachi K, Arimoto T, Wada-Hiraike O, Oda K, Nagamatsu T, Osuga Y, Fujii T. Nakamura H, et al. Among authors: inoue t. Int J Oncol. 2016 Nov;49(5):2155-2162. doi: 10.3892/ijo.2016.3681. Epub 2016 Sep 6. Int J Oncol. 2016. PMID: 27599897
Expression of Par3 polarity protein correlates with poor prognosis in ovarian cancer.
Nakamura H, Nagasaka K, Kawana K, Taguchi A, Uehara Y, Yoshida M, Sato M, Nishida H, Fujimoto A, Inoue T, Adachi K, Nagamatsu T, Arimoto T, Oda K, Osuga Y, Fujii T. Nakamura H, et al. Among authors: inoue t. BMC Cancer. 2016 Nov 17;16(1):897. doi: 10.1186/s12885-016-2929-2. BMC Cancer. 2016. PMID: 27855669 Free PMC article.
Regeneration of cervical reserve cell-like cells from human induced pluripotent stem cells (iPSCs): A new approach to finding targets for cervical cancer stem cell treatment.
Sato M, Kawana K, Adachi K, Fujimoto A, Yoshida M, Nakamura H, Nishida H, Inoue T, Taguchi A, Ogishima J, Eguchi S, Yamashita A, Tomio K, Wada-Hiraike O, Oda K, Nagamatsu T, Osuga Y, Fujii T. Sato M, et al. Among authors: inoue t. Oncotarget. 2017 Jun 20;8(25):40935-40945. doi: 10.18632/oncotarget.16783. Oncotarget. 2017. PMID: 28402962 Free PMC article.
Intracellular signaling entropy can be a biomarker for predicting the development of cervical intraepithelial neoplasia.
Sato M, Kawana K, Adachi K, Fujimoto A, Yoshida M, Nakamura H, Nishida H, Inoue T, Taguchi A, Ogishima J, Eguchi S, Yamashita A, Tomio K, Wada-Hiraike O, Oda K, Nagamatsu T, Osuga Y, Fujii T. Sato M, et al. Among authors: inoue t. PLoS One. 2017 Apr 28;12(4):e0176353. doi: 10.1371/journal.pone.0176353. eCollection 2017. PLoS One. 2017. PMID: 28453530 Free PMC article.
Therapeutic significance of targeting survivin in cervical cancer and possibility of combination therapy with TRAIL.
Nakamura H, Taguchi A, Kawana K, Baba S, Kawata A, Yoshida M, Fujimoto A, Ogishima J, Sato M, Inoue T, Nishida H, Furuya H, Yamashita A, Eguchi S, Tomio K, Mori-Uchino M, Adachi K, Arimoto T, Wada-Hiraike O, Oda K, Nagamatsu T, Osuga Y, Fujii T. Nakamura H, et al. Among authors: inoue t. Oncotarget. 2018 Feb 5;9(17):13451-13461. doi: 10.18632/oncotarget.24413. eCollection 2018 Mar 2. Oncotarget. 2018. PMID: 29568369 Free PMC article.
11,562 results
You have reached the last available page of results. Please see the User Guide for more information.